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Abstract Anterior cruciate ligament (ACL) reconstruc-
tion has the best chance for success when the graft
undergoes extensive biologic remodeling and incorporation
after implantation. There are many factors that can lead to
graft failure and possible revision surgery. These include
patient selection; surgical technique such as graft place-
ment and tensioning; the use of allograft versus autograft;
mechanical factors such as secondary restraint laxity; lack
of a correct, carefully controlled post-operative rehabilita-
tion program; and biological factors. When a patient
presents with knee instability following ligament recon-
struction and there is no history of a new trauma or
identifiable technical error, biological failure should be
considered. However, the biologic response of the grafted
tissue is closely linked to the mechanical and biochemical
environment into which the graft is placed. Thus, the
‘‘biological failure’’ of the ACL graft is a complex patho-
logical entity whose cause is not fully understood. Failure
may be initiated by early extensive graft necrosis, distur-
bances in revascularization, problems in cell repopulation
and proliferation, and as well difficulties in the ligamenti-
zation process. However, further study of the biological
characterization of a failed graft placed in a correct
mechanical environment is warranted.
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Introduction
In the past decades major improvements have been made in
anterior cruciate ligament (ACL) reconstructive surgery,
thus surgical reconstruction is now widely accepted as the
treatment of choice for individuals with functional instability
due to an ACL-deficient knee [1]. Nonetheless, 0.7–10% of
patients develop graft failure with recurrent instability [2–6]
and may then be candidates for revision ACL reconstruction.
Failure is likely to be considered when a patient reports
functional instability with sports or activities of daily liv-
ing, a decreased frequency or level of athletic activity with
respect to pre-injury status, increased pain, loss of motion,
recurrent episodes of giving way, increased pathologic
anterior laxity on physical examination with a positive
Lachman or pivot shift test, and greater than 5 mm side-to-
side difference on arthrometric testing [7]. The University
of Pittsburgh group [6] classified the mechanisms of ACL
graft failure as related to (a) surgical technique; (b) graft
incorporation; and (c) trauma (Table 1). In addition, indi-
vidual patient factors such as healing potential and
compliance undoubtedly play a role in graft failure.
Technical failure is frequently implicated in revision
cases, up to 77% in one series [8]. Specific reasons for
technical failure include non-anatomic tibial and/or femo-
ral tunnel placement; inadequate notchplasty leading to
impingement; improper graft tensioning; graft fixation
failure; choice and cross sectional area of the graft tissue;
error in graft selection between autograft, allograft and
occasionally synthetic graft; and laxity of the secondary
restraints. Traumatic failure may occur shortly after the
initial surgery, before graft incorporation, due to an overly
aggressive physical therapy program during the early
rehabilitation period. Or may happen later in cases of
traumatic re-rupture, often in athletic individuals.
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Failure of graft incorporation and ligamentization (as
described by Amiel et al. [13]), is commonly referred to as
‘‘biological failure’’ of the ACL graft. It is a complex entity
related to problems in the biological processes that directly
interact with biomechanical factors to transform the graft
into a newly functional ACL [9]. Indeed most grafts used to
substitute for a deficient ACL, whether they be allograft or
autograft tendon, are histologically and biomechanically
different from the native ACL. Tendons consist of 30%
collagen and 2% elastin embedded in an extracellular matrix
containing 68% water. Collagen, synthesized by fibroblasts,
forms 70% of the dry weight of a tendon and has a breaking
point similar to that of steel. Elastin contributes to the ten-
don’s flexibility. The ground substance is necessary for the
aggregation of collagenous proteins into a fibrillar. Fibro-
blasts are long, tapered cells often found among collagen
bundles. They are seen as thin flat nuclei, and are motile and
highly proliferative. They form collagen, elastin, and
ground matrix, and increase in number during wound
healing [10]. Ligaments are fibrous connective tissues
comprised of ground substance (water and proteoglycans),
cells (primarily fibroblasts), and fibrous elements (collagen,
elastin, and reticulin). Ligaments are composed mostly of
water (60–80% net weight) and type I collagen (65–80% dry
weight). The ground substance (approximately 1% dry
weight) consists primarily of proteoglycans, which serve to
hold water. Ligaments also contain small amounts of actin,
fibronectin, and other substances of unknown significance,
and are relatively avascular with low blood flow [11].
Compared to tendons, ligaments are metabolically more
active, have plumper fibroblast nuclei, higher DNA content
(more cells), more type III collagen, more proteoglycans,
less total collagen, and a different proportion of reducible
intermolecular collagen bonds [12]. In a rabbit model,
Amiel et al. demonstrated that autografts undergo a liga-
mentization process, defined as a transition of the
biomechanical and histologic parameters of the graft from
tendinous to ligamentous in appearance. This remodeling of
the graft tissue occurs in the new intra-articular environment
specific to the native ACL [13], and while it is complex,
ingenious and leads to a fully incorporated graft, it does not
result in a duplication of the native ACL.
Animal and human models have shown the stages of this
ligamentization process, which includes avascular necrosis,
revascularization, cellular repopulation, collagen remodel-
ing, and maturation [14, 15]. In the context of the current
literature, this article discusses the ‘‘biological failure’’ of
the ACL graft, specifically its definition, possible causes
and its consequences. The objective is to summarize what
is known, what is not known, and the possibilities for
further research.
Definition
As a general concept, failure of an ACL graft should be
considered when restoration of stability and return to activity
have not been achieved in a patient who has undergone ACL
reconstruction. Without a history of a new trauma, and in the
presence of a knee without laxity of the secondary restraints
and no detectable technical errors, one can entertain the
diagnosis of ‘‘biological failure’’. This definition lacks pre-
cision, is not very satisfying, and is more a diagnosis
established by exclusion of other causes of failure.
Biological failure can also be defined as a failure in the
completion of the ligamentization process, leading to an
atonic, disorganized, and non-viable graft (Fig. 1). Marumo
et al. [16] explained the changes that might occur in the
collagen concentrations and biochemical profiles of the ACL
graft. As the center of the transplanted tissue is initially
avascular with relatively low numbers of viable cells, col-
lagen synthesis cannot be very active in the early
postoperative months, even though vascular invasion from
the surface of the graft occurs within 3 to 8 weeks after the
reconstruction and is followed by a repopulation phase [17–
19]. Increased revascularization, release of growth factors by
viable cells that enter the graft tissue through the newly
formed vessels, and mechanical forces all stimulate collagen
production. Collagen content increases with time and may
become even higher than in the native ACL, probably
because of a higher cell density and collagen over-expression
during the first year after the initial surgery. The conversion
Table 1 University of Pittsburgh classification for mech-
anisms of ACL graft failure
A. Surgical technique
1. Technical errors
Tunnel location
Graft impingement
Graft tension
Graft fixation
2. Mechanical/biomechanical factors
Graft strength (size, hamstring versus BPTB, irradiation)
Synthetic graft
3. Secondary stabilizers
Combined ligament involvement
Meniscal/articular cartilage loss
B. Failure of graft incorporation
1. Avascularity
2. Immunology
3. Stress shielding
C. Trauma
1. Traumatic re-injury
2. Aggressive rehabilitation
Reprinted with permission from Johnson et al. [55]
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of collagen cross-linkage from reducible (tendons) into non-
reducible (ligaments) occurs simultaneously with collagen
synthesis and mechanical stress, as well as with other intra-
articular factors that might contribute to this re-arrangement
(and thus ligamentization) [16]. In order to determine the
histology of ACL grafts that failed to incorporate, Alm et al.
[20] performed biopsies on 22 patients who were 3 months to
5 1/2 years following patellar tendon autograft ACL recon-
struction. They found central necrosis of the grafts and
complete vascularization by 8 weeks. In those with intact
grafts, the histology resembled a normal ACL except for
continued hypercellularity. In those grafts that were ruptured
or clinically lax, histology revealed disintegration and
fragmentation of the collagen with gross disorganization of
the graft component parts [20, 21]. Malinin et al. also found
that lax grafts remained histologically disorganized for up to
3 years post-implantation [22].
Thus, a microscopic definition of biological failure
appears more reliable and appropriate. If greater than
1 year post-implantation a lax graft shows extensive
necrosis, hypocellularity, poor vascularization, disintegra-
tion, fragmentation, and disorganization of the collagen, it
should be considered as biologically failed.
The biologic response of the grafted collagenous tissue
is intimately linked to the biomechanical and biochemical
environment into which the graft is placed [23]. As pre-
viously mentioned, ‘‘biological failure’’ is a concept still
under investigation and should remain a diagnosis of
exclusion. The following section details the biological
mechanisms that might lead to failure of graft incorpora-
tion. These include graft necrosis, revascularization, cell
repopulation, collagen remodeling and ligamentization,
immunologic response, and stress shielding.
Biological factors
Graft necrosis
In the first 3–4 weeks following implantation most authors
agree that the graft undergoes avascular necrosis mainly in
its central portion [13, 24–26]. As part of this necrotic
process, several cytokines are released and initiate the
cascade of growth factors that guide the different incor-
poration steps such as revascularization, cell migration and
proliferation [27, 28]. Extended necrosis could result due to
the major biological changes occurring within the intra-
articular environment after the operation. It has been shown
[29, 30] that levels of matrix-metalloproteinase (MMP3),
tissue inhibitor of metalloproteinase (TIMP)-1, interleukin-
6 and 8 (IL-6, IL-8), tumor necrosis factor alpha (TNF-a),
interleukine-1 (IL-1), and low density of interleukin-1
receptor antagonist (IRAP) are increased in the ACL-
injured knee, and the same response may occur after ACL
reconstruction. Such changes may create an antagonistic
environment for the newly grafted tissue and result in
extended necrosis, collagen disturbance (disintegration,
fragmentation, disorganization), myxoid degeneration and
finally interfering with the process of revascularization.
However, clinical observation of failed grafts rarely shows
complete disappearance of the grafted tissue, implying that
necrosis is a limited process in most cases.
Revascularization
Since the ACL graft undergoes necrosis following implan-
tation [24], adequate revascularization is critical for
successful graft incorporation by allowing cellular repopu-
lation and subsequent matrix remodeling. Indeed, early
revascularization of the ACL graft brings in viable cells which
release growth factors and produce collagen typically char-
acteristic of ligamentous tissue. At 3 weeks, post-operative
grafts show early revascularization and are well perfused by
6–8 weeks. Graft revascularization has been shown to pre-
dominantly originate from the infrapatellar fat pad distally
and from the posterior synovial tissues proximally. Conse-
quently, during notch preparation, one must avoid aggressive
shaving of the fat pad and the posterior synovial tissue, to
enhance the revascularization process [14, 31].
The major causes for impairment of revascularization
include: (a) Over-tensioning of the ACL graft, which
induces focal myxoid degeneration and marked changes in
its histologic appearance. This suggests that graft should be
Fig. 1 Loose, atone and
avascular ACL hamstring graft
2 years post-implantation.
Despite a large volume of
collagen, the graft is
incompetent and disorganized
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fixed under optimal preload [32]; (b) Patients habits,
including smoking, cocaine consumption, or systemic dis-
eases such as diabetes. Cocaine-associated cerebral
vasculitis has been described, and biopsies of brain tissue
reveal a non-necrotizing leukocytoplastic angiitis of the
small vessels [33]. This same mechanism may interfere
with revascularization of the ACL graft leading to the cases
of biological failure we have observed among cocaine
abusers (Fig. 2). In diabetic patients, microangiopathies
may lead to the same phenomenon. In smokers, nicotine is a
potent vasoconstrictor [34] and inhaled carbon monoxide
reduces tissue oxygenation and impairs the microcirculation
within healing soft tissue and bone [35, 36]. While these
patient factors may theoretically contribute to the failure of
graft revascularization and incorporation, Karim et al. [37]
did not report on specific biological failure among smokers;
(c) Choice of graft, whereby revascularization and cell
repopulation have been demonstrated to occur earlier with
autograft versus allograft [15], and allografts have been
shown to be revascularized and remodeled superficially
with incomplete healing in the central portion of the graft
[38]; (d) Hypoxia during the period of avascular necrosis. It
has been shown that VEGF expression is up-regulated
during the early phase following graft implantation [39],
and in situations of extended graft necrosis and destruction
of engrafted cells the missing trigger for angiogenesis, and
the resulting decreased expression of VEGF, may cause
failure of the revascularization process.
Cellular repopulation and proliferation
Cellular repopulation with mesenchymal stem cells and
regenerative fibroblasts, as well as revascularization, have
been shown to be completed 12 weeks after surgery. This
correlates with the presence of PDGF-AA, PDGF-BB and
Fig. 2 Anterior cruciate
ligament (ACL) graft 1 year
post-implantation in a
professional football player
abusing of drugs (cocaine,
amphetamine, methadone). a
T1-MRI view in the ACL plane.
b Coronal T2 MRI view. c
Arthroscopic view of the loose
and atone graft. d The graft is
disorganized. e Definitively
loose at palpation. f The graft
has been cut transversally
allowing for the distinction of
superficial layers with
vasculature and central zone
(arrows) avascular and necrotic
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TGF-b1 in the reconstructed graft and these growth fac-
tors are not present in the native ACL [28]. Further
studies are needed to clarify the exact role of these
growth factors but it can be assumed that a lack of them
could lead to biological failure. A deficient revasculari-
zation process results in a lack of available oxygen for
cells, thus limiting growth factor production. Since these
growth factors have an autocrine and paracrine action
their decrease will result in a diminution of cell prolif-
eration as has already been shown in vitro [40–43]. This
phenomenon will clearly interfere with the ligamentiza-
tion process that follows.
Collagen remodeling and Ligamentization
For many years, it has been known that collagen fibrils in
the reconstructed ligament are differently organized than
those of the native ACL [44], having a unimodal, small
diameter collagen-fibril diameter profile [45, 46] and the
remodeling process never results in exact reproduction of
the original ligament organization. However, this liga-
mentization process is crucial to restore the mechanical
properties of the graft. Total collagen content and the non-
reducible/reducible crosslink ratio increase within one year
after graft implantation [16]. Collagen production requires
sufficient revascularization, release of growth factors by
viable cells, and adequate mechanical forces. Obviously,
the failure of one of these parameters impairs the entire
process. The conversion of collagen cross-links from
reducible into non-reducible occurs simultaneously with
collagen synthesis and mechanical stress [16]. As previ-
ously mentioned the mechanical environment of the graft
directly influences these changes, and this depends more
upon surgical technique and the rehabilitation regimen than
biology. Tunnel placement is currently thought to be the
most critical factor in determining ACL reconstruction
success or failure, because tunnel placement directly
affects the mechanical properties of the graft and therefore
directly affects the ligamentization process of the healing
graft. For example, a femoral tunnel that is positioned too
anterior, results in a lack of the parallel alignment of col-
lagen fibers and leads to collagen fiber fragmentation [21].
Thus, loss in graft mechanical properties may be related to
non-physiologic graft position and tension, instead of being
the consequence of the remodeling process. It appears clear
that rather than being a biological failure, this represents a
technical failure [47].
As concerns ligamentization, we observed two cases of
extensive hypertrophy of the grafted tissue, and one case of
bone metaplasia within the graft itself (Fig. 3). Despite the
increased content of tissue, theses grafts were loose and
atonic with a decrease in cell density and highly
disorganized collagen bundles. We have no explanation for
this phenomenon.
Immunology
It has been demonstrated that allografts harvested under
sterile conditions (non-irradiated, non-gas sterilized) and
fresh-frozen before implantation often lead to bone
resorption and tunnel enlargement [48]. Tunnel enlarge-
ment is a failure of graft incorporation. While the incidence
of tunnel enlargement is significantly higher in patients
following allograft as compared to autograft, the explana-
tion is unknown, but may be due to immunologic reaction
enhanced by the allograft [48]. Indeed, Harner et al. [49]
found a significant donor-specific immune response in
patients who had undergone fresh frozen bone-patellar
tendon-bone allograft ACL reconstruction, with the
expression of IgG antibody to donor human leukocyte
antigen-class I antigen. Arnoczky et al. [31] reported
reduced graft antigenicity associated with deep freezing in
comparison with the marked rejection and inflammatory
response in the fresh specimens. They hypothesized that
the freezing process may denature cell surface marker
proteins and disrupt cell membranes, thereby reducing
antigenicity [31]. Thus, immunologic reactions may
explain why the rate of incorporation is dependent upon the
type of graft material and the method of fixation. For
example, Jackson et al. [47] demonstrated that allografts
have a longer and less complete course of incorporation
and remodeling when compared with autografts, and that
the allografts were shown to be biomechanically inferior to
the autografts. This slower histologic incorporation may
result in diminished graft function [47]. However, there is
Fig. 3 BPTB ACL graft containing ossification. Bone can be seen in
the mid-substance of the implanted ACL graft (arrow) and in its distal
portion 3 years after the surgery
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no evidence in the literature that allograft reconstruction
leads to a higher rate of biological failure.
Stress shielding
Graft tensioning during surgery and the postoperative
rehabilitation program have to be balanced to permit
optimal graft healing. It is agreed that the ACL graft is only
incorporated in the presence of mechanical loading, but the
magnitude of this load has yet to be determined. Shel-
bourne and Nitz [50] showed that patients who returned
quickly to high-risk activities achieved normal function
earlier than those who complied with the postoperative
regimen. However, patients undergoing aggressive reha-
bilitation have developed degenerative changes in the
reconstructed ligaments [T. Yamagishi et al. (2000),
unpublished data], and clinical studies have indicated that
an early return to vigorous physical activity may increase
the risk of greater knee laxity after ACL reconstruction
with either a patellar tendon (BPTB) [51, 52] or hamstring
graft (StG) [53]. Yoshiya, et al. [32] showed that long-term
knee stability may be dependent on initial tensioning, and
that over-tensioning ACL grafts may adversely affect their
biologic incorporation, leading to delayed graft incorpo-
ration, myxoid degeneration, decreased graft strength, and
over-constraining the joint. Beynnon et al. [54] demon-
strated during knee flexion intraoperatively that graft
elongation values outside the limits of the ACL resulted in
a significant increase in anterior laxity at a 5 year follow-
up, while grafts with elongation values similar to the nor-
mal ACL did not do so.
In summary, the ACL graft heals only if the recon-
struction can restore the anatomy of the native ACL and
mimic as closely as possible the biomechanical environ-
ment of an intact ACL.
Discussion
Biological ACL graft failure is a complex pathological
entity not completely understood. Any factors affecting
graft revascularization, cellular repopulation, or matrix
remodeling can lead to biological failure. However, the
biologic response of the grafted collagenous tissue is inti-
mately linked to the biomechanical and biochemical
environment into which the graft is placed. Therefore, graft
failure may often result from the inability to precisely
reproduce physiologic tension and position, and is not a
consequence of the remodeling process [23, 47]. Graft
incorporation is influenced by many factors, primarily
technical and biomechanical, and cannot always be
appreciated objectively. It is difficult to appreciate the
concept of genuine biological failure, and the diagnosis of
‘‘biological failure of an ACL graft’’ should be considered
more as an exclusion diagnosis rather than a real patho-
logical entity.
Most of our knowledge concerning ACL graft incorpo-
ration comes from animal models, but human biopsy
studies have shown that there are important differences in
graft healing between human and animals. Thus animal
data cannot be directly transferred to the human, although
they do provide substantial help in understanding the bio-
logical processes. Further human studies are needed to
clarify this concept of biological ACL graft failure, to
understand its pathogenicity, and mainly the ways to pre-
vent and to treat its occurrence. At present, we do know
that the biological response of the engrafted tissue is inti-
mately related to the mechanical and biochemical
environment into which the graft is placed. The surgeon is
directly responsible for the mechanical aspects, and the
patient, is responsible for providing the appropriate bio-
chemical environment. Therefore each of these factors
must be considered individually in our approach to ACL
reconstructive surgery.
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